XML 93 R85.htm IDEA: XBRL DOCUMENT
v3.25.0.1

License Agreement with Duke - Additional Information (Detail) - USD ($) |  | 3 Months Ended | 12 Months Ended |
--- | --- | --- | --- | ---
Mar. 03, 2023 | Nov. 30, 2023 | Nov. 30, 2024 | Nov. 30, 2023 | Nov. 30, 2021
Patent Option And Technology License Agreement [Line Items] |  |  |  |  |
Impairment of assets |  | $ 13,108,064 | $ 0 | $ 13,108,064 |
Duke University [Member] |  |  |  |  |
Patent Option And Technology License Agreement [Line Items] |  |  |  |  |
Amount on excess damages |  |  | $ 100,000,000 |  |
Milestone payments first phase III clinical trial | $ 2,000,000 |  |  |  |
Capitalized costs to obtain agreement |  |  |  |  | $ 15,372,382
Capitalized costs amortization period |  |  | 16 years |  |
Amortization expense |  |  | $ 0 | $ 960,774 |
Duke University [Member] | Maximum [Member] |  |  |  |  |
Patent Option And Technology License Agreement [Line Items] |  |  |  |  |
Additional capital related to research |  |  | $ 350,000 |  |
Research Agreement [Member] |  |  |  |  |
Patent Option And Technology License Agreement [Line Items] |  |  |  |  |
Consideration payable for research | $ 187,400 |  |  |  |

X
- Definition Additional capital related to research. + References No definition available. + Details
Name: | ccel_AdditionalCapitalRelatedToResearch
Namespace Prefix: | ccel_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount on excess damages. + References No definition available. + Details
Name: | ccel_AmountOnExcessDamages
Namespace Prefix: | ccel_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of consideration payable for research + References No definition available. + Details
Name: | ccel_ConsiderationPayableForResearch
Namespace Prefix: | ccel_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Milestone payments. + References No definition available. + Details
Name: | ccel_MilestonePayments
Namespace Prefix: | ccel_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Patent option and technology license agreement. + References No definition available. + Details
Name: | ccel_PatentOptionAndTechnologyLicenseAgreementLineItems
Namespace Prefix: | ccel_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 340 -SubTopic 40 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479483/340-40-50-3 + Details
Name: | us-gaap_CapitalizedContractCostAmortization
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amortization period of cost capitalized in obtaining or fulfilling contract with customer, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -SubTopic 40 -Topic 340 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479483/340-40-50-2 + Details
Name: | us-gaap_CapitalizedContractCostAmortizationPeriod
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 340 -SubTopic 40 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479483/340-40-50-3 + Details
Name: | us-gaap_CapitalizedContractCostNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount recognized as an operating expense or loss during the period to reduce the carrying amount of a project that has been impaired but not abandoned. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (b) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 45 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482130/360-10-45-4 + Details
Name: | us-gaap_ImpairmentOfOngoingProject
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=ccel_DukeUniversityMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=ccel_ResearchAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |